scholarly article | Q13442814 |
P50 | author | David K. Shay | Q38641565 |
Richard Zimmerman | Q42658961 | ||
Edward A Belongia | Q59829972 | ||
Arnold S. Monto | Q59829998 | ||
Mary Patricia Nowalk | Q63170708 | ||
Michael L Jackson | Q88969073 | ||
Joshua G Petrie | Q89457943 | ||
Mark G. Thompson | Q91141663 | ||
Lois Lamerato | Q96231796 | ||
Lisa A Jackson | Q97556689 | ||
Charles R Rinaldo | Q102058793 | ||
Suzanne E Ohmit | Q104720751 | ||
Manjusha Gaglani | Q106490274 | ||
Swathi N Thaker | Q114338918 | ||
Lydia Clipper | Q114338922 | ||
Jennifer K Meece | Q114338925 | ||
P2093 | author name string | Po-Yung Cheng | |
Juhee Song | |||
Marcus Zervos | |||
Sarah M Spencer | |||
Pedro Piedra | |||
P2860 | cites work | Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities | Q28741469 |
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe | Q28742719 | ||
The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study | Q30400700 | ||
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
Influence of prior influenza vaccination on antibody and B-cell responses | Q33361605 | ||
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 | Q34129986 | ||
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season | Q34294175 | ||
Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population | Q35191251 | ||
Variable efficacy of repeated annual influenza vaccination | Q36705674 | ||
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains | Q36854011 | ||
What does self rated health measure? Results from the British Whitehall II and French Gazel cohort studies | Q36933716 | ||
Influenza vaccine effectiveness in the community and the household | Q36956943 | ||
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses | Q37397023 | ||
Multiple genotypes of influenza B virus circulated between 1979 and 2003. | Q37596513 | ||
The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. | Q40027900 | ||
Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults | Q41326434 | ||
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period | Q45760959 | ||
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity | Q46107360 | ||
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. | Q50637887 | ||
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. | Q51168887 | ||
Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. | Q53091538 | ||
Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season | Q56770384 | ||
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? | Q80208528 | ||
Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection | Q85094818 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
influenza vaccine | Q383260 | ||
P304 | page(s) | 319-327 | |
P577 | publication date | 2013-11-13 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | |
P478 | volume | 58 |
Q38410159 | 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type |
Q57452617 | A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates from Observational Studies |
Q36991782 | A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season |
Q90409521 | A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly |
Q61445511 | A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines |
Q36389642 | A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants |
Q38692107 | A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children. |
Q30396097 | Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains |
Q38729900 | Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort |
Q38864751 | Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness |
Q98568367 | Assessment of indirect protection from maternal influenza immunization among non-vaccinated household family members in a randomized controlled trial in Sarlahi, Nepal |
Q36957563 | Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States |
Q36633673 | Association between Psychological Flexibility and Health Beliefs in the Uptake of Influenza Vaccination among People with Chronic Respiratory Diseases in Hong Kong |
Q34106198 | Association between antibody titers and protection against influenza virus infection within households |
Q38950526 | Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. |
Q50065275 | Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness |
Q47678684 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons |
Q92915035 | Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort |
Q47548718 | Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis |
Q36141965 | Classification and Regression Tree (CART) analysis to predict influenza in primary care patients |
Q39242282 | Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination |
Q90621783 | Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season |
Q42145296 | Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness |
Q38614227 | Cost effectiveness of a practice-based intervention to improve vaccination rates in adults less than 65-years-old |
Q47692575 | Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults |
Q40713908 | Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly |
Q64124882 | Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study |
Q30373099 | Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14. |
Q30383252 | Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans. |
Q34770845 | Detection of influenza virus infection using two PCR methods |
Q39215322 | Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Post-vaccination Sera |
Q50044242 | Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine |
Q35589650 | Does Influenza Vaccination Modify Influenza Severity? Data on Older Adults Hospitalized With Influenza During the 2012-2013 Season in the United States |
Q53283393 | Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis. |
Q54513872 | Editorial Commentary: Influenza Vaccine Effectiveness: A Glass Both Half Full and Half Empty. |
Q64130248 | Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016 |
Q36783231 | Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults |
Q30401497 | Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus |
Q30391150 | Effect of Statin Use on Influenza Vaccine Effectiveness |
Q30403059 | Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain |
Q41109359 | Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States |
Q38378102 | Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season |
Q34451202 | Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies |
Q40107978 | Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates |
Q40015287 | Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. |
Q92942088 | Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019 |
Q98578103 | Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine |
Q37568436 | Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. |
Q51660857 | Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. |
Q40094268 | Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns. |
Q38587366 | Efficacy and effectiveness of live attenuated influenza vaccine in school-age children |
Q40670577 | Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. |
Q52627557 | Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines. |
Q41694953 | Estimated influenza illnesses and hospitalizations averted by vaccination--United States, 2013-14 influenza season |
Q30400623 | Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States |
Q58722425 | Estimating Vaccine-Driven Selection in Seasonal Influenza |
Q92499114 | Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017 |
Q64130596 | Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population |
Q59351771 | Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study |
Q52805071 | Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17. |
Q39375320 | Factors affecting immune responses to the influenza vaccine |
Q37159633 | Factors associated with maternal influenza immunization decision-making. Evidence of immunization history and message framing effects |
Q40140855 | Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes |
Q34974842 | Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons |
Q64276594 | HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy |
Q52845428 | Hintergrundpapier der STIKO: Evaluation der bestehenden Influenzaimpfempfehlung für Indikationsgruppen und für Senioren (Standardimpfung ab 60 Jahren). |
Q38408953 | Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14. |
Q42592060 | How can we solve the enigma of influenza vaccine-induced protection? |
Q40734674 | Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio |
Q36497877 | Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013 |
Q59349308 | Immune History and Influenza Vaccine Effectiveness |
Q39088963 | Immune history and influenza virus susceptibility |
Q37560954 | Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis |
Q36705828 | Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness |
Q64136777 | Impact of repeated influenza vaccinations in persons over 65 years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17 |
Q34393525 | Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons |
Q47564122 | Impact of seasonal influenza vaccination in the presence of vaccine interference |
Q52315590 | Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance. |
Q41053454 | Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons |
Q41201663 | Increasing herd immunity with influenza revaccination |
Q30391418 | Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination |
Q47549841 | Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States |
Q42242172 | Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine |
Q30397977 | Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement |
Q44292787 | Influenza Vaccination of Patients Receiving Statins: Where Do We Go From Here? |
Q30383312 | Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. |
Q38406947 | Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. |
Q38756456 | Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014. |
Q58110187 | Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017 |
Q37568360 | Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses |
Q36446113 | Influenza Vaccine Effectiveness in a Low-Income, Urban Community Cohort |
Q40089214 | Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season |
Q59352861 | Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season |
Q90041536 | Influenza Vaccine Intention After a Medically Attended Acute Respiratory Infection |
Q90678295 | Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season |
Q33776771 | Influenza vaccination and treatment in children with neurologic disorders |
Q40261504 | Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers |
Q47137946 | Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada |
Q38417597 | Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study. |
Q40068128 | Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season |
Q42201843 | Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China |
Q36783905 | Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings |
Q42187912 | Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. |
Q40191494 | Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014 |
Q39833076 | Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16 - a rapid epidemiological and virological assessment |
Q86127719 | Influenza vaccine effectiveness in elderly people |
Q35715694 | Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility |
Q54277492 | Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. |
Q38408870 | Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15. |
Q34505958 | Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain |
Q57530834 | Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015 |
Q58124629 | Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010/11 to 2015/16 |
Q35531934 | Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type |
Q89041842 | Influenza vaccine failure: failure to protect or failure to understand? |
Q47889238 | Influenza vaccine response: future perspectives |
Q94601233 | Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China |
Q36358260 | Intention to receive influenza vaccine after an acute respiratory illness |
Q38957414 | Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. |
Q30359268 | Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. |
Q42237299 | Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. |
Q41474318 | Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. |
Q64126022 | Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment |
Q41510419 | Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-Analysis |
Q47386997 | Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community |
Q35667123 | Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice |
Q35705382 | Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015 |
Q39837983 | Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season |
Q91801945 | Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season |
Q40280573 | Moving Toward Improved Influenza Vaccines |
Q88632441 | Multimorbidity is associated with uptake of influenza vaccination |
Q39422605 | Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan |
Q57093953 | Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity |
Q47709222 | On the bias of estimates of influenza vaccine effectiveness from test-negative studies |
Q64132510 | Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons |
Q36306922 | Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination |
Q41930762 | Perspectives from the society for pediatric research (SPR): Decreased effectiveness of the live attenuated influenza vaccine (LAIV). |
Q47605953 | Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission. |
Q39813068 | Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. |
Q34778408 | Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review |
Q64134459 | Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) |
Q40152643 | Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States |
Q38995372 | Protection of children against influenza: Emerging problems |
Q97530377 | Quantifying the annual incidence and underestimation of seasonal influenza: A modelling approach |
Q36403075 | Quantifying the economic value and quality of life impact of earlier influenza vaccination |
Q59357833 | Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women |
Q98497953 | Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19 |
Q92214805 | Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans |
Q40280348 | Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza |
Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
Q49400944 | Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. |
Q91941703 | Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets |
Q47814632 | Reply to: Estimating the Full Value of High-Dose Influenza Vaccine |
Q35557380 | Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women |
Q30360610 | Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals. |
Q33619841 | School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015. |
Q36518793 | Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine |
Q40146222 | Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013. |
Q30383722 | Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach |
Q92686229 | Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018 |
Q35997473 | Socioeconomic Disparities and Influenza Hospitalizations, Tennessee, USA. |
Q35225209 | Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult Korean populations |
Q30381731 | Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated |
Q40248207 | The Doctrine of Original Antigenic Sin: Separating Good From Evil |
Q47700569 | The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia |
Q41919202 | The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q100528502 | The challenges of vaccine strain selection |
Q36131193 | The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines |
Q34194443 | The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. |
Q92084109 | The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18 |
Q36207731 | The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012 |
Q38639994 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q60912426 | The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis |
Q92640448 | The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada |
Q47287114 | The impact of selection bias on vaccine effectiveness estimates from test-negative studies |
Q34354261 | Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season |
Q26796300 | Vaccination of healthcare workers: A review |
Q39961932 | Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. |
Q36385284 | Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease |
Q38803189 | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies |
Search more.